Cargando…

Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study

CONTEXT: There is little information about fatty liver in prediabetes as it transitions to early diabetes. OBJECTIVE: This study is aimed at evaluating the prevalence and determinants of fatty liver in the Diabetes Prevention Program (DPP). METHODS: We measured liver fat as liver attenuation (LA) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldberg, Ronald B, Tripputi, Mark T, Boyko, Edward J, Budoff, Matthew, Chen, Zsu-Zsu, Clark, Jeanne M, Dabelea, Dana M, Edelstein, Sharon L, Gerszten, Robert E, Horton, Edward, Mather, Kieren J, Perreault, Leigh, Temprosa, Marinella, Wallia, Amisha, Watson, Karol, Irfan, Zeb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530730/ https://www.ncbi.nlm.nih.gov/pubmed/33705543 http://dx.doi.org/10.1210/clinem/dgab160

Ejemplares similares

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021)

Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
por: Perreault, Leigh, et al.
Publicado: (2014)

Lifestyle and Metformin Interventions Have a Durable Effect to Lower CRP and tPA Levels in the Diabetes Prevention Program Except in Those Who Develop Diabetes
por: Goldberg, Ronald B., et al.
Publicado: (2014)

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
por: Crandall, Jill P, et al.
Publicado: (2017)

Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program
por: Aroda, Vanita R, et al.
Publicado: (2020)

Erratum. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care 2017;40:1668–1677
por: Herman, William H., et al.
Publicado: (2018)

Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668—1677
por: Herman, William H., et al.
Publicado: (2019)

A parametric bootstrap approach for computing confidence intervals for genetic correlations with application to genetically-determined protein-protein networks
por: Tsai, Yi-Ting, et al.
Publicado: (2023)

Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program
por: Varga, Tibor V, et al.
Publicado: (2021)

Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group
por: Goldberg, Ronald B., et al.
Publicado: (2009)

Comparison of ETDRS 7-Field to 4-Widefield Digital Imaging in the Evaluation of Diabetic Retinopathy Severity
por: Blodi, Barbara A., et al.
Publicado: (2022)

Massive Thymic Hyperplasia Masquerading as Cancer: A Case Report and Review of the Literature
por: Gatof, Emily Stern, et al.
Publicado: (2023)

Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study
por: Nathan, D. M., et al.
Publicado: (2015)

Surface Electrical Impedance Myography Detects Skeletal Muscle Atrophy in Aged Wildtype Zebrafish and Aged gpr27 Knockout Zebrafish
por: Rutkove, Seward B., et al.
Publicado: (2023)

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
por: Rodgers, Megan, et al.
Publicado: (2021)

Effects of Genetic Variants Previously Associated with Fasting Glucose and Insulin in the Diabetes Prevention Program
por: Florez, Jose C., et al.
Publicado: (2012)

Comment on Menke et al. Metals in Urine and Diabetes in U.S. Adults. Diabetes 2016;65:164–171
por: Wong, Winifred P., et al.
Publicado: (2016)

Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans
por: Chen, Zsu-Zsu, et al.
Publicado: (2022)

Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
por: Ngo, Debby, et al.
Publicado: (2021)

Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2008)

Continuous Wavelet Transform Analysis of Acceleration Signals Measured from a Wave Buoy
por: Chuang, Laurence Zsu-Hsin, et al.
Publicado: (2013)

Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study
por: Sam, Susan, et al.
Publicado: (2021)

Genetic Architecture of Plasma Alpha‐Aminoadipic Acid Reveals a Relationship With High‐Density Lipoprotein Cholesterol
por: Shi, Mingjian, et al.
Publicado: (2022)

Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods
por: Katz, Daniel H., et al.
Publicado: (2022)

SUN-LB029 A Case of Gestational Diabetes with Diabetic Ketoacidosis, Insulin Injection Site Reaction and Anti Insulin Antibodies in Pregnancy
por: Hakimian, Stephanie, et al.
Publicado: (2019)

Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps
por: Wallia, Amisha, et al.
Publicado: (2020)

Coronary Artery Calcium Screening: Does it Perform Better than Other Cardiovascular Risk Stratification Tools?
por: Zeb, Irfan, et al.
Publicado: (2015)

Conservation of the Eastern Taiwan Strait Chinese White Dolphin (Sousa chinensis): Fishers' Perspectives and Management Implications
por: Liu, Ta-Kang, et al.
Publicado: (2016)

Cohort Profile: The Stockholm Diabetes Prevention Programme (SDPP)
por: Gudjonsdottir, Hrafnhildur, et al.
Publicado: (2022)

Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study
por: Walker, Elizabeth Arquin, et al.
Publicado: (2020)

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)

CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels
por: Tanzo, Julia T., et al.
Publicado: (2023)

The C Allele of ATM rs11212617 Does Not Associate With Metformin Response in the Diabetes Prevention Program
por: Florez, Jose C., et al.
Publicado: (2012)

Correlates of second-line type 2 diabetes medication selection in the USA
por: Ackermann, Ronald T, et al.
Publicado: (2017)

Risk assessment of the hospital discharge process of high-risk patients with diabetes
por: Pollack, Teresa A, et al.
Publicado: (2018)

An Escape From Diabetes
por: Rasouli, Neda
Publicado: (2020)

Corrigendum to: “Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study”
Publicado: (2021)

Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort
por: Cho, Nam H, et al.
Publicado: (2019)

Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population
por: Wallia, Amisha, et al.
Publicado: (2021)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
por: Tsang, Venessa H M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_off85h0fce18itt2ehhr3jafqf